Safety and feasibility of anti-CD19 CAR T cells expressing inducible IL-7 and CCL19 in patients with relapsed or refractory large B-cell lymphoma - Wen Lei; Ai Zhao; Hui Liu; Chunmei Yang; Cheng Wei; Shanshan Guo; Zhilu Chen; Qunyi Guo; Linjie Li; Mingzhe Zhao; Gongqiang Wu; Guifang Ouyang; et al. (Cell Discovery, 2024)